Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 61-72 of 800 results.
"The rising incidence of microplastics (MPs) is a possible health risk to humans. The present study aims to analyze the presence of MPs in intravenous (IV) infusions and compare MP concentrations from multiple brands" Casella et al (2025).
"The recently described SIUVeC (Safe Insertion Umbilical Venous Catheter) protocol incorporates all the innovations suggested by the latest literature, with the intention of reducing the risk associated with this procedure. The purpose of this paper is to report the outcomes of the systematic implementation of this protocol" Barone et al (2025).
"The implementation of smart infusion pump interoperability has the potential to enhance patient safety by reducing pADEs and improving outpatient administration charge capture" Borrelli et al (2025).
"This article presents a case of an 80-year-old female who developed iatrogenic air emboli from CVC manipulation leading to left middle cerebral artery (MCA) syndrome due to suspected right-to-left shunt from pulmonary arteriovenous malformation (pulmonary AVM) or patent foramen ovale (PFO)" Reyhanoglu et al (2025).
"Our data suggest that CVL preservation in pediatric IF patients with Candida sp CLABSI is feasible without increased complications or mortality. Limitations include small sample size and retrospective design" Khan et al (2025).
"By integrating features such as patient-specific anatomical variability, realistic resistance feedback, and adaptive difficulty levels, virtual reality and haptic simulations can closely replicate the nuances of IV insertion in diverse clinical scenarios" Jarzembak et al (2025).
"We retrospectively analyzed how peripherally inserted central venous catheter (PICC) failure and the associated complications affected patient outcomes" Masuda et al (2025).
"By combining audits, education, and feedback, this study will provide key insights into the effectiveness of education-based interventions for improving CVC-related practices in critical care settings" Khanafer et al (2025).
"It is necessary to know the rate of phlebitis associated with its use and the risk factors associated with peripheral vascular catheter management that directly influence the presence of phlebitis" Ferraz-Torres et al (2025).
"This position paper is intended for clinicians and data managers involved in the diagnosis, management, and reporting of bloodstream (BSI) and central venous catheter (CVC)-related BSI (CRBSI) and CVC-related local skin/soft-tissue infections (lSSTI) in haematopoietic cell transplant (HCT) recipients" Averbuch et al (2025).
"TIVADs may be prioritized for pediatric chemotherapy when feasible, taking into account factors such as cost, provider expertise, and patient preference" Liu et al (2025).
"To assess which of the formulae for estimating renal function (Cockcroft-Gault (CG), Chronic Kidney Disease Epidemiology Collaboration CKD-EPI) and Modification of Diet in Renal Disease (MDRD)) provides the most accurate prediction of minimum vancomycin concentration (Cmin) and to evaluate whether they can be interchanged to optimise vancomycin dosage" Gratacós et al (2025).
